Cargando…
Burden of albinism: development and validation of a burden assessment tool
BACKGROUND: Albinism comprises a group of autosomal recessive diseases that are characterized by poor vision and a variable hypopigmentation phenotype. A comprehensive literature review showed that no tool can assess the burden experienced by individuals who present with albinism, although such a to...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145119/ https://www.ncbi.nlm.nih.gov/pubmed/30227882 http://dx.doi.org/10.1186/s13023-018-0894-3 |
_version_ | 1783356205273448448 |
---|---|
author | Morice-Picard, Fanny Taïeb, Charles Marti, Aurelie Gliksohn, Antoine Bennani, Mohammed Bodemer, Christine Ezzedine, Khaled |
author_facet | Morice-Picard, Fanny Taïeb, Charles Marti, Aurelie Gliksohn, Antoine Bennani, Mohammed Bodemer, Christine Ezzedine, Khaled |
author_sort | Morice-Picard, Fanny |
collection | PubMed |
description | BACKGROUND: Albinism comprises a group of autosomal recessive diseases that are characterized by poor vision and a variable hypopigmentation phenotype. A comprehensive literature review showed that no tool can assess the burden experienced by individuals who present with albinism, although such a tool is needed and would be beneficial for clinicians and patients alike. METHOD: The questionnaire was devised using standardized methodology for developing and validating questionnaires on the quality of life of subjects according to the following chronological structure: conceptual phase, development phase, and then validation phase. A multidisciplinary working group was assembled, including experts on questionnaire design and development, dermatologists specializing in care for patients with albinism, and representatives of the Genespoir association. RESULTS: Based on an initial verbatim report, the workgroup compiled a list of items that were transcribed and reformulated into questions. During the validation phase, principal component analysis (PCA) was conducted on the 24 items, which allowed the questionnaire to be reduced to 20 questions [Q]. The standardized regression coefficients were all greater than 0.5 for their corresponding factors. Based on their normalized regression coefficients, each group of questions was linked to one of the following four dimensions, with each dimension consisting of at least three questions: “Live with” (8 Q), “Daily life” (3 Q), “Resignation” (3 Q), and “Fear of the future” (6 Q). All dimensions correlated well with the overall BoA score. Cronbach’s α was 0.92 for the entire BoA scale, confirming excellent internal coherence. Intradimensional coherences all demonstrated excellent reliability (α > 0.65). The BoA questionnaire was highly correlated with the SF12, RSES and DLQI validated questionnaires. This outcome confirmed the external validity. CONCLUSION: This questionnaire represents the first specific assessment tool for evaluating the burden of albinism. It is easy to use and relatively quick to complete, which will allow the burden to be evaluated over time with a reproducible questionnaire. To ensure that this questionnaire can be used by as many people as possible, cultural and linguistic validation in US English was conducted with the original French version. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13023-018-0894-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6145119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61451192018-09-24 Burden of albinism: development and validation of a burden assessment tool Morice-Picard, Fanny Taïeb, Charles Marti, Aurelie Gliksohn, Antoine Bennani, Mohammed Bodemer, Christine Ezzedine, Khaled Orphanet J Rare Dis Research BACKGROUND: Albinism comprises a group of autosomal recessive diseases that are characterized by poor vision and a variable hypopigmentation phenotype. A comprehensive literature review showed that no tool can assess the burden experienced by individuals who present with albinism, although such a tool is needed and would be beneficial for clinicians and patients alike. METHOD: The questionnaire was devised using standardized methodology for developing and validating questionnaires on the quality of life of subjects according to the following chronological structure: conceptual phase, development phase, and then validation phase. A multidisciplinary working group was assembled, including experts on questionnaire design and development, dermatologists specializing in care for patients with albinism, and representatives of the Genespoir association. RESULTS: Based on an initial verbatim report, the workgroup compiled a list of items that were transcribed and reformulated into questions. During the validation phase, principal component analysis (PCA) was conducted on the 24 items, which allowed the questionnaire to be reduced to 20 questions [Q]. The standardized regression coefficients were all greater than 0.5 for their corresponding factors. Based on their normalized regression coefficients, each group of questions was linked to one of the following four dimensions, with each dimension consisting of at least three questions: “Live with” (8 Q), “Daily life” (3 Q), “Resignation” (3 Q), and “Fear of the future” (6 Q). All dimensions correlated well with the overall BoA score. Cronbach’s α was 0.92 for the entire BoA scale, confirming excellent internal coherence. Intradimensional coherences all demonstrated excellent reliability (α > 0.65). The BoA questionnaire was highly correlated with the SF12, RSES and DLQI validated questionnaires. This outcome confirmed the external validity. CONCLUSION: This questionnaire represents the first specific assessment tool for evaluating the burden of albinism. It is easy to use and relatively quick to complete, which will allow the burden to be evaluated over time with a reproducible questionnaire. To ensure that this questionnaire can be used by as many people as possible, cultural and linguistic validation in US English was conducted with the original French version. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13023-018-0894-3) contains supplementary material, which is available to authorized users. BioMed Central 2018-09-18 /pmc/articles/PMC6145119/ /pubmed/30227882 http://dx.doi.org/10.1186/s13023-018-0894-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Morice-Picard, Fanny Taïeb, Charles Marti, Aurelie Gliksohn, Antoine Bennani, Mohammed Bodemer, Christine Ezzedine, Khaled Burden of albinism: development and validation of a burden assessment tool |
title | Burden of albinism: development and validation of a burden assessment tool |
title_full | Burden of albinism: development and validation of a burden assessment tool |
title_fullStr | Burden of albinism: development and validation of a burden assessment tool |
title_full_unstemmed | Burden of albinism: development and validation of a burden assessment tool |
title_short | Burden of albinism: development and validation of a burden assessment tool |
title_sort | burden of albinism: development and validation of a burden assessment tool |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145119/ https://www.ncbi.nlm.nih.gov/pubmed/30227882 http://dx.doi.org/10.1186/s13023-018-0894-3 |
work_keys_str_mv | AT moricepicardfanny burdenofalbinismdevelopmentandvalidationofaburdenassessmenttool AT taiebcharles burdenofalbinismdevelopmentandvalidationofaburdenassessmenttool AT martiaurelie burdenofalbinismdevelopmentandvalidationofaburdenassessmenttool AT gliksohnantoine burdenofalbinismdevelopmentandvalidationofaburdenassessmenttool AT bennanimohammed burdenofalbinismdevelopmentandvalidationofaburdenassessmenttool AT bodemerchristine burdenofalbinismdevelopmentandvalidationofaburdenassessmenttool AT ezzedinekhaled burdenofalbinismdevelopmentandvalidationofaburdenassessmenttool AT burdenofalbinismdevelopmentandvalidationofaburdenassessmenttool |